TY  - JOUR
A1  - Jain, Dr Saloni
A1  - Akhtar, Jawed
A1  - Siyag, Ramdev
A1  - Danis, Mohd
A1  - Anas, Mohd
ID  - arxiv87615
Y1  - 2026/04/23/
UR  - https://universalpublishings.com/index.php/siad/article/view/17883
KW  - CRISPR-Cas9; Gene Editing; Casgevy; Sickle Cell Disease; Base Editing
AV  - none
JF  - SYNAPSES: INSIGHTS ACROSS THE DISCIPLINES
N1  - Imported from Universal Publishings (OAI id oai:ojs.pkp.sfu.ca:article/17883)
TI  - THE GENETIC REVOLUTION: How CRISPR and Gene Editing Are Reshaping Medicine, Ethics, and Our Future
PB  - Research Science and Innovation House
N2  - Gene editing represents one of the most transformative biotechnologies of the 21st century, offering unprecedented precision in modifying DNA to treat genetic diseases, enhance agricultural productivity, and potentially alter the trajectory of human evolution. This narrative article explores the revolutionary CRISPR-Cas9 technology, its clinical applications including the landmark FDA approval of Casgevy for sickle cell disease, emerging ethical frameworks, and the regulatory landscape shaping this rapidly evolving field. With the global gene editing market projected to reach $45 billion by 2035 , understanding this technology's capabilities, limitations, and societal implications has never been more critical.
ER  -